ZFIN ID: ZDB-FISH-200820-1
Fish name: AB/TU + MO3-vgll4l
Genotype: AB/TU
Targeting Reagent: MO3-vgll4l
HUMAN DISEASE MODELED by AB/TU + MO3-vgll4l
No data available
GENE EXPRESSION
Gene expression in AB/TU + MO3-vgll4l
RNA expression
Expressed Gene Structure Conditions Figures
abcc6a standard conditions Figure 4 with image from Fillatre et al., 2019
atp6ap1b standard conditions Figure 4 with image from Fillatre et al., 2019
cdc14aa standard conditions Figure 4 with image from Fillatre et al., 2019
cfap45 standard conditions Figure 4 with image from Fillatre et al., 2019
cftr standard conditions Figure 4 with image from Fillatre et al., 2019
cldn5a standard conditions Figure 4 with image from Fillatre et al., 2019
daw1 standard conditions Figure 4 with image from Fillatre et al., 2019
dhrs13a.1 standard conditions Figure 4 with image from Fillatre et al., 2019
dnaaf4 standard conditions Figure 4 with image from Fillatre et al., 2019
dnmt3bb.1 standard conditions Figure 4 with image from Fillatre et al., 2019
dnmt3bb.2 standard conditions Figure 4 with image from Fillatre et al., 2019
mbd3b standard conditions Figure 4 with image from Fillatre et al., 2019
ndr1 standard conditions Figure 4 with image from Fillatre et al., 2019
nme5 standard conditions Figure 4 with image from Fillatre et al., 2019
odad4 standard conditions Figure 4 with image from Fillatre et al., 2019
quo standard conditions Figure 4 with image from Fillatre et al., 2019
rasgef1ba standard conditions Figure 4 with image from Fillatre et al., 2019
rassf7b standard conditions Figure 4 with image from Fillatre et al., 2019
si:ch73-364h19.1 standard conditions Figure 4 with image from Fillatre et al., 2019
slc35d1a standard conditions Figure 4 with image from Fillatre et al., 2019
sypl2b standard conditions Figure 4 with image from Fillatre et al., 2019
tekt1 standard conditions Figure 4 with image from Fillatre et al., 2019
tnfrsf21 standard conditions Figure 4 with image from Fillatre et al., 2019
vgll4l standard conditions Figure 4 with image from Fillatre et al., 2019
Protein expression No data available
Reporter gene expression No data available
PHENOTYPE
Phenotype in AB/TU + MO3-vgll4l
Phenotype Conditions Figures
determination of heart left/right asymmetry disrupted, abnormal standard conditions Figure 1 with imageFigure 9 from Fillatre et al., 2019
forerunner cell group dnaaf4 expression absent, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group cfap45 expression absent, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group dhrs13a.1 expression absent, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group ndr1 expression absent, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group cftr expression absent, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group si:ch73-364h19.1 expression absent, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group quo expression absent, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group cldn5a expression absent, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group dnmt3bb.2 expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group odad4 expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group rassf7b expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group dnmt3bb.1 expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group abcc6a expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group cdc14aa expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group daw1 expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group mbd3b expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group slc35d1a expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group tekt1 expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group rasgef1ba expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group sypl2b expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group vgll4l expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group nme5 expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group atp6ap1b expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
forerunner cell group tnfrsf21 expression decreased amount, abnormal standard conditions Figure 4 with image from Fillatre et al., 2019
heart jogging process quality, abnormal standard conditions Figure 1 with imageFigure 9 from Fillatre et al., 2019
heart tube mislocalised, abnormal standard conditions Figure 1 with imageFigure 9 from Fillatre et al., 2019

CITATIONS  (1)